Identification of D1-like dopamine receptors on human blood platelets

Jacques De Keyser, M. De Waele, A. Convents, Guy Ebinger, G. Vauquelin

Onderzoeksoutput: Article

27 Citaten (Scopus)


Dopamine is able to inhibit the epinephrine-induced aggregation of human blood platelets, but the mechanism of action has not been elucidated. In this study we report that membranes from human blood platelets possess high affinity, saturable and stereoselective binding sites for the D1 dopamine receptor antagonist (3H) SCH 23390. (3H) SCH 23390 appeared to label a single class of binding sites with a Bmax of 18.6 +/- 1.6 fmol/mg protein and a KD of 0.8 nM. The potencies of different dopaminergic antagonists and agonists in displacing (3H) SCH 23390 from blood platelet membranes were similar to those obtained for striatal membranes. Unlike the classically defined D1 receptors, e.g. those in striatum, the D1 receptor sites on platelets appeared not to be coupled to the adenylate cyclase system, hence the term "D1-like". The D1 agonist SKF 38393 was more potent than dopamine in inhibiting platelet aggregation induced by epinephrine, and the effects of dopamine and SKF 38393 were prevented by SCH 23390. These results suggest that the inhibitory action of dopamine on the epinephrine-induced platelet aggregation is mediated through these D1-like receptors.
Originele taal-2English
Pagina's (van-tot)1797-1806
Aantal pagina's10
TijdschriftLife Sci
StatusPublished - 1988


Duik in de onderzoeksthema's van 'Identification of D1-like dopamine receptors on human blood platelets'. Samen vormen ze een unieke vingerafdruk.

Citeer dit